Autoimmune Disease Testing Market Opportunities, Emerging Technologies 2029

The autoimmune disease testing market size was USD 4.84 billion in 2021 and is projected to grow from USD 5.52 billion in 2022 to USD 10.75 billion by 2029, exhibiting a CAGR of 10.0%. Based on our analysis, the global market exhibited a decline of -7.1% in 2020 as compared to 2019.

A new research publication focusing on "Autoimmune Disease Testing Market" has been released by Fortune Business Insights. This extensive industry report provides an introduction to new trends that can help businesses in the Autoimmune Disease Testing Market industry understand the market and develop growth strategies accordingly. The report examines the market scope, industry segments, key drivers for development, major segments, and SWOT analysis.

For More Information: https://www.fortunebusinessinsights.com/autoimmune-disease-testing-market-104460  

The market report offers valuable insights on the industrial base, productivity, strengths, manufacturers, and recent trends, which can help businesses expand and achieve financial growth. It covers a range of dynamic factors like segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. The report also includes details of recent collaborations, mergers, acquisitions, and partnerships, as well as regulatory frameworks across different regions that impact the market trajectory. Furthermore, the report highlights recent technological advances and innovations influencing the global market.

Top Key Vendors of this Autoimmune Disease Testing Market are:

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Siemens Healthcare GmbH (Germany)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • Abbott (U.S.)
  • Werfen (Spain)
  • Trinity Biotech (Ireland)
  • Bio-Rad Laboratories, Inc. (U.S.)  

Market Drivers

The rapid increase in the prevalence of autoimmune diseases such as scleroderma, rheumatoid arthritis, and inflammatory bowel disease is a concerning trend. Several factors contribute to this surge, including genetics, environmental factors, certain hormones, and susceptibility to certain infections. These factors can enhance a person's risk of developing autoimmune diseases.

For instance, a study published in the American Journal of Managed Care (AJMC) in May 2021 estimated that the prevalence of scleroderma in adults in the U.S. was approximately 276 cases per million. This highlights the significant impact of autoimmune diseases on the population.

 

It's crucial to continue research and raise awareness about autoimmune diseases to better understand their causes, develop effective treatments, and improve patients' quality of life. 

Request A Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/104460

Regional Analysis for Autoimmune Disease Testing Market:

The North America market has emerged as a dominant force in the global market for autoimmune disease detection, with a valuation of USD 2.13 billion in 2021. This supremacy can be attributed to several factors, including the widespread adoption of technologically advanced tests for the detection of autoimmune diseases in the region.

Furthermore, North America has witnessed numerous strategic initiatives that have contributed to its apex market position. For instance, in January 2020, Progentec Diagnostics, Inc. secured funding of USD 5.0 million. The company plans to utilize this investment to develop a comprehensive solution for managing lupus patients through continuous remote digital monitoring, ensuring high levels of sensitivity and specificity.

Moreover, the region's market growth is anticipated to be supported by increased focus on research and development (R&D) for the development of new testing options. These advancements will enhance the accuracy, efficiency, and scope of autoimmune disease detection and management.

With North America's commitment to technological advancements and strategic initiatives, the market for autoimmune disease detection is projected to experience significant growth during the forecast period. 

Speak To Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/104460

Report contents include:

  • Historical data and forecast.
  • Analysis of the Autoimmune Disease Testing Market market including revenues, future growth, market outlook.
  • Regional analysis including growth estimates.
  • Analyzes the end user markets including growth estimates.
  • Profiles on Autoimmune Disease Testing Market including products, sales/revenues, and market position.
  • Market structure, market drivers, and restraints.

Ask For Customization: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/104460

Related Reports:

Orthodontics Market

Autoimmune Disease Testing Market

Degenerative Disc Disease Treatment Market

Sickle Cell Disease Treatment Market

Immunology Market

Gene Therapy

About us:

Fortune Business Insights™ provides accurate data and innovative enterprise analytics to help organizations of all sizes make better decisions. We tailor novel solutions for our clients to help them meet a variety of unique business challenges. Our aim is to provide a detailed overview of the markets in which they operate to provide holistic market intelligence.

Address:

Fortune Business Insights Pvt .

9th Floor, Icon Tower, Burner –

Pune-411045,

India, Maharashtra.

Telephone:

USA: +1 424 253 0390

UK: +44 2071 939123

Asia Pacific: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Comments

Popular posts from this blog

Sedation In ICU Setting Market | Global Challenges, Demand, Trends, and Future Opportunities Forecast Till 2023-2029

Deep Brain Stimulation (DBS) Devices Market Discovers the Opportunities, Management to 2026

Medical Tourism Market Size, Industry Growth and Forecast to 2028